Guardian Pharmacy Services, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2026 Annual Meeting of Stockholders held by Guardian Pharmacy Services, Inc. on May 5, 2026. The filing details the voting outcomes for four proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following proposals were voted upon at the Annual Meeting:
- Proposal 1 (Election of Class II Directors): Stockholders elected John Ackerman and Randall Lewis. Both nominees received significant support, with approximately 44.7 million and 44.8 million votes "For" respectively.
- Proposal 2 (Say-on-Pay): Stockholders approved the compensation of Named Executive Officers on a non-binding advisory basis. The vote was 53,758,195 "For" versus 500,207 "Against."
- Proposal 3 (Frequency of Say-on-Pay): Stockholders approved holding future advisory votes on executive compensation on an annual basis (1-year frequency). The vote was 52,068,050 for 1 year.
- Proposal 4 (Auditor Ratification): Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2026. The vote was 55,073,124 "For" versus 91,887 "Against."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.
Investor Verification Checklist
- Verify the term length for the newly elected Class II Directors (until the 2029 annual meeting).
- Confirm the Company's commitment to annual Say-on-Pay votes based on the Proposal 3 results.
- Review the full proxy statement for details on the specific executive compensation packages approved in Proposal 2.
- Check subsequent filings for the 2026 audited financial statements prepared by Ernst & Young LLP.